Lenvatinib
Brand name: Lenvima
Lenvatinib comes in 10 pill versions in our database, in 8 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Lenvatinib pill images
4 mg 2 pills
- E LENV 4 mg Lenvatinib 4 mg Red, capsule, 14 mm Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02484056 Lenvatinib Mesylate 4 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
8 mg 1 pill
10 mg 2 pills
- E LENV 10 mg Lenvatinib 10 mg Red & yellow, capsule, 14 mm Used for renal cell carcinoma and thyroid neoplasms
- No picture yet DIN 02450321 Lenvatinib Mesylate 10 mg Lenvima, Capsule, sold in Canada Used for renal cell carcinoma and thyroid neoplasms
12 mg 1 pill
14 mg 1 pill
18 mg 1 pill
20 mg 1 pill
24 mg 1 pill
What is Lenvatinib used for?
Lenvatinib is used for renal cell carcinoma and thyroid neoplasms.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Differentiated Thyroid Cancer
LENVIMA is indicated for the treatment of adult patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC).
Renal Cell Carcinoma
LENVIMA, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC).
LENVIMA, in combination with everolimus, is indicated for the treatment of adult patients with advanced RCC following one prior anti-angiogenic therapy.
Hepatocellular Carcinoma
LENVIMA is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC).
Endometrial Carcinoma
LENVIMA, in combination with pembrolizumab, is indicated for the treatment of patients with advanced endometrial carcinoma (EC) that is mismatch repair proficient (pMMR) or not microsatellite instability-high (MSI-H), as determined by an FDA-approved test, who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.
From the FDA-approved label on DailyMed (published Jun 30, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.